ALK and cancer: Following the binding of a ligand to its extracellular domain, ALK undergoes dimerization and subsequent autophosphorylation of its intracellular kinase domain, thereby activating the downstream oncogenic pathways, including the mitogen-activated protein kinase (MAPK) signaling cascades, which promote cancer growth and transformation [49].